Optimum population-level use of artemisinin combination therapies: a modelling study
Background: Artemisinin combination therapies (ACTs) are used worldwide as first-line treatment against confirmed or suspected Plasmodium falciparum malaria. Despite the success of ACTs at reducing the global burden of malaria, emerging resistance to artemisinin threatens these gains. Countering ons...
Main Authors: | Tran Dang Nguyen, BSc, Piero Olliaro, Prof. Arjen M Dondorp, MD, Prof. J Kevin Baird, PhD, Ha Minh Lam, MSc, Jeremy Farrar, MD, Prof. Guy E Thwaites, MD, Prof. Nicholas J White, MD, Dr. Maciej F Boni |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-12-01
|
Series: | The Lancet Global Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214109X1500162X |
Similar Items
-
Age-related disparities in diabetes risk attributable to modifiable risk factor profiles in Chinese adults: a nationwide, population-based, cohort study
by: Tiange Wang, ProfPhD, et al.
Published: (2021-10-01) -
Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study
by: Jasper Tromp, MD, et al.
Published: (2020-03-01) -
Mortality and morbidity 1 year after stopping a remote patient management intervention: extended follow-up results from the telemedical interventional management in patients with heart failure II (TIM-HF2) randomised trial
by: Friedrich Koehler, ProfMD, et al.
Published: (2020-01-01) -
Symptom Oriented Pain Management- A review
by: Prof. (Dr.) Dwarkadas Baheti MD
Published: (2019-08-01) -
Lifestyle factors and risk of sickness absence from work: a multicohort study
by: Marianna Virtanen, ProfPhD, et al.
Published: (2018-11-01)